Loading…
CARE for All Kidneys Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Coordination, Accountability, Research, and Equity for All Kidneys Act of 2021 or the CARE for All Kidneys Act of 2021 This bill requires multiple agencies to address kidney disease, with a focus on minority, rural, and other underserved populations that are disproportionately affected by the disease. First, the Department of Health and Human Services (HHS) must study patterns of care for kidney disease provided through certain health insurance providers. Second, HHS's Office of the Assistant Secretary for Health must (1) create a plan to address kidney disease, (2) develop a pilot program for best practices to diagnose and manage the disease, and (3) report annually on the impact of a Medicare model that encourages greater use of home dialysis and kidney transplants. Third, the National Institutes of Health must expand research on kidney disease. This includes research on the causes of lower rates of, and interventions to increase, kidney transplants among underserved populations. Fourth, the National Institute of Diabetes and Digestive and Kidney Diseases must conduct an awareness campaign and work with the Centers for Disease Control and Prevention (CDC) to evaluate data collection concerning kidney disease. Fifth, the CDC must award grants for public health interventions to reduce the burden of kidney disease and undertake activities to identify and address environmental and occupational causes of kidney disease. Last, the bill makes kidney disease specialists eligible for the National Health Service Corps (NHSC). The NHSC provides scholarships and student loan repayment awards to health care providers who agree to work in areas with shortages of primary care, mental health, and dental providers.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (9)
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2022 · fourth_quarter · Health Issues
H.R. 8594/S. 4750, the Restore Protections for Dialysis Patients Act H.R. 7845/ the NIH Clinical Trial Diversity Act H.R. 1255/S. 377, the Living Donor Protection Act H.R. 1676, the Jack Reynold Medigap Expansion Act H.R. 526, Ensuring Coverage in Public Health Emergencies Act of 2021 Health disparities S. 1002, the Junk Plan Accountability and Disclosure Act of 2021 H.R. 4065/S. 1971, the Chronic Kidney Disease Improvement in Research and Treatment Act of 2021. H.R. 3893, the CARE for All Kidneys Act FY 2023, Labor-HHS-Education Appropriations Act H.R. 7585, the Health Equity and Accountability Act of 2022 (HEAA) H.R. 5801, the Help Ensure Lower Patient (HELP) Copays Act H.R. 7667, the Food and Drug Amendments of 2022 H.R. 7506, the New Era for Preventing End-Stage Kidney Disease Act of 2022 Medicare Program; Implementing Certain Provisions of the Consolidated Appropriations Act, 2021 and Other Revisions to Medicare Enrollment and Eligibility Rules Diversity Plans To Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry Request for Information on ways to strengthen and improve the Organ Procurement and Transplantation Network
Client expense: $160,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
Covid-19 recovery and response efforts for ESRD patients. HR 1676 - The Jack Reynolds Memorial Medigap Expansion Act HR 1255 - Living Donor Protection Act of 2021 S. 377 - Living Donor Protection Act of 2021 HR 3893 - CARE for All Kidneys Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R. 1730, S. 670, Speeding Therapy Access Today Act of 2021; H.R. 3893, Coordination, Accountability, Research, and Equity for All Kidneys Act of 2021. Congressional consideration of the Prescription Drug User Fee Act. H.R. 6963, Accelerated Approval Integrity Act, and H.R. 6996, Accelerated Access for Patient Act, and Senate proposals regarding expedited FDA pathways. H.R. 7506, the New Era of Preventing End-Stage Kidney Disease. H.R.2471, Consolidated Appropriations Act, 2022.
Client expense: $190,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); S. 1971, Chronic Kidney Disease Improvement in Research and Treatment Act of 2021; H.R. 4065, To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes; End-Stage Renal Disease (ESRD) payment reform and quality metrics; S. 377/H.R. 1255, Living Donor Protection Act; H.R. 1676, Jack Reynolds Memorial Medigap Expansion Act H.R. 3893, Coordination, Accountability, Research and Equity for All Kidneys Act of 2021 (CARE for All Kidneys Act); H.R. 2934, Renal Anemia Innovation Support and Expansion (RAISE) Act; End Stage Renal Disease (ESRD) Prospective Payment System (PPS) and utilization of calcimimetic drugs; Medicare Secondary Payer; H.R. 7878/S. 4307 Kidney Health Connect Act of 2022; Calendar Year 2023 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Final Rule (CMS-1768-F); H.R. 8594/S. 4750, Restore Protections for Dialysis Patients Act
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · fourth_quarter · Health Issues
Charitable premium assistance and end-stage renal disease issues; H.R. 1255/S. 377 Living Donor Protection Act; CARE for All Kidneys Act (H.R. 3893)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Organ and tissue donation and transplantation policy, awareness and education; H.R. 3893 - CARE for All Kidneys Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
Medicare organ and tissue donation and transplantation regulatory policy, awareness and education; H.R. 3893 - Care for All Kidneys Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Covid-19 recovery and response efforts for ESRD patients. HR 1676 - The Jack Reynolds Memorial Medigap Expansion Act HR 1255 - Living Donor Protection Act of 2021 S. 377 - Living Donor Protection Act of 2021 HR 3893 - CARE for All Kidneys Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
H.R. 8594/S. 4750, the Restore Protections for Dialysis Patients Act H.R. 7845/ the NIH Clinical Trial Diversity Act H.R. 1255/S. 377, the Living Donor Protection Act H.R. 1676, the Jack Reynold Medigap Expansion Act H.R. 526, Ensuring Coverage in Public Health Emergencies Act of 2021 Health disparities S. 1002, the Junk Plan Accountability and Disclosure Act of 2021 H.R. 4065/S. 1971, the Chronic Kidney Disease Improvement in Research and Treatment Act of 2021. H.R. 3893, the CARE for All Kidneys Act FY 2023, Labor-HHS-Education Appropriations Act H.R. 7585, the Health Equity and Accountability Act of 2022 (HEAA) H.R. 5801, the Help Ensure Lower Patient (HELP) Copays Act H.R. 7667, the Food and Drug Amendments of 2022 H.R. 7506, the New Era for Preventing End-Stage Kidney Disease Act of 2022 Medicare Program; Implementing Certain Provisions of the Consolidated Appropriations Act, 2021 and Other Revisions to Medicare Enrollment and Eligibility Rules Diversity Plans To Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry Request for Information on ways to strengthen and improve the Organ Procurement and Transplantation Network
Client expense: $150,000 · Firm income: Not reported
2022 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 1730, S. 670, Speeding Therapy Access Today Act of 2021; H.R. 3893, Coordination, Accountability, Research, and Equity for All Kidneys Act of 2021. Congressional consideration of the Prescription Drug User Fee Act. H.R. 6963, Accelerated Approval Integrity Act, and H.R. 6996, Accelerated Access for Patient Act, and Senate proposals regarding expedited FDA pathways. H.R. 7506, the New Era of Preventing End-Stage Kidney Disease.
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · third_quarter · Medicare/Medicaid
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); S. 1971, Chronic Kidney Disease Improvement in Research and Treatment Act of 2021; H.R. 4065, To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes; End-Stage Renal Disease (ESRD) payment reform and quality metrics; S. 377/H.R. 1255, Living Donor Protection Act; H.R. 1676, Jack Reynolds Memorial Medigap Expansion Act H.R. 3893, Coordination, Accountability, Research and Equity for All Kidneys Act of 2021 (CARE for All Kidneys Act); H.R. 2934, Renal Anemia Innovation Support and Expansion (RAISE) Act; End Stage Renal Disease (ESRD) Prospective Payment System (PPS) and utilization of calcimimetic drugs; Medicare Secondary Payer; H.R. 7878/S. 4307 Kidney Health Connect Act of 2022; Calendar Year 2023 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Proposed Rule, issued 6/21/22; H.R. 8594/S. 4750, Restore Protections for Dialysis Patients Act
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Charitable premium assistance and end-stage renal disease issues; H.R. 1255/S. 377 Living Donor Protection Act; CARE for All Kidneys Act (H.R. 3893)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
Medicare organ and tissue donation and transplantation regulatory policy, awareness and education; H.R. 3893 - Care for All Kidneys Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · second_quarter · Health Issues
Organ and tissue donation and transplantation policy, awareness and education; H.R. 3893 - CARE for All Kidneys Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · third_quarter · Health Issues
Organ and tissue donation and transplantation policy, awareness and education; H.R. 3893 - CARE for All Kidneys Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
Medicare organ and tissue donation and transplantation regulatory policy, awareness and education; H.R. 3893 - Care for All Kidneys Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Covid-19 recovery and response efforts for ESRD patients. HR 1676 - The Jack Reynolds Memorial Medigap Expansion Act HR 1255 - Living Donor Protection Act of 2021 S. 377 - Living Donor Protection Act of 2021 HR 3893 - CARE for All Kidneys Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · second_quarter · Health Issues
Charitable premium assistance and end-stage renal disease issues; H.R. 1255/S. 377 Living Donor Protection Act; CARE for All Kidneys Act (H.R. 3893)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
H.R. 1255/S. 377, the Living Donor Protection Act H.R. 1676, the Jack Reynold Medigap Expansion Act H.R. 526, Ensuring Coverage in Public Health Emergencies Act of 2021 Health disparities S. 1002, the Junk Plan Accountability and Disclosure Act of 2021 H.R. 4065/S. 1971, the Chronic Kidney Disease Improvement in Research and Treatment Act of 2021. H.R. 3893, the CARE for All Kidneys Act FY 2023, Labor-HHS-Education Appropriations Act H.R. 7585, the Health Equity and Accountability Act of 2022 (HEAA) H.R. 5801, the Help Ensure Lower Patient (HELP) Copays Act H.R. 7845, NIH Clinical Trial Diversity Act of 2022 H.R. 7667, the Food and Drug Amendments of 2022 H.R. 7506, the New Era for Preventing End-Stage Kidney Disease Act of 2022 Medicare Program; Implementing Certain Provisions of the Consolidated Appropriations Act, 2021 and Other Revisions to Medicare Enrollment and Eligibility Rules Diversity Plans To Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry Request for Information on ways to strengthen and improve the Organ Procurement and Transplantation Network
Client expense: $130,000 · Firm income: Not reported
2022 · second_quarter · Medicare/Medicaid
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); S. 1971, Chronic Kidney Disease Improvement in Research and Treatment Act of 2021; H.R. 4065, To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes; End-Stage Renal Disease (ESRD) payment reform and quality metrics; S.377/H.R. 1255, Living Donor Protection Act; H.R. 1676, Jack Reynolds Memorial Medigap Expansion Act H.R. 3893, Coordination, Accountability, Research and Equity for All Kidneys Act of 2021 (CARE for All Kidneys Act); H.R. 2934, Renal Anemia Innovation Support and Expansion (RAISE) Act; End Stage Renal Disease (ESRD) Prospective Payment System (PPS) and utilization of calcimimetic drugs; Medicare Secondary Payer; H.R. 7878/S. 4307 Kidney Health Connect Act of 2022; Calendar Year 2023 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Proposed Rule, issued 6/21/22
Client expense: Not reported · Firm income: $70,000
2022 · second_quarter · Medicare/Medicaid
Medicare organ and tissue donation and transplantation regulatory policy, awareness and education; H.R. 3893 - Care for All Kidneys Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · second_quarter · Health Issues
Organ and tissue donation and transplantation policy, awareness and education; H.R. 3893 - CARE for All Kidneys Act of 2021.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · second_quarter · Medical/Disease Research/Clinical Labs
H.R. 1730, S. 670, Speeding Therapy Access Today Act of 2021; H.R. 3893, Coordination, Accountability, Research, and Equity for All Kidneys Act of 2021. Congressional consideration of the Prescription Drug User Fee Act. H.R. 6963, Accelerated Approval Integrity Act, and H.R. 6996, Accelerated Access for Patient Act, and Senate proposals regarding expedited FDA pathways. H.R. 7506, the New Era of Preventing End-Stage Kidney Disease
Client expense: $290,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · first_quarter · Health Issues
H.R. 1255/S. 377, the Living Donor Protection Act H.R. 1676, the Jack Reynold Medigap Expansion Act H.R. 526, Ensuring Coverage in Public Health Emergencies Act of 2021 Increasing FMAP (Federal Medicare Assistance Percentage) Health disparities S. 1002, the Junk Plan Accountability and Disclosure Act of 2021 Organ Procurement Organizations Conditions for Coverage: Revisions to the Outcome Measure Requirements for Organ Procurement Organizations Part D Payment Modernization (PDM) Model for plan year 2022 Charitable Premium Assistance H.R. 3912/S. 1971, the Chronic Kidney Disease Improvement in Research and Treatment Act of 2021. H.R. 3893, the CARE for All Kidneys Act FY 2022, Labor-HHS-Education Appropriations Act
Client expense: $190,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · first_quarter · Health Issues
Covid-19 recovery and response efforts for ESRD patients. HR 1676 - The Jack Reynolds Memorial Medigap Expansion Act HR 1255 - Living Donor Protection Act of 2021 S. 377 - Living Donor Protection Act of 2021 HR 3893 - CARE for All Kidneys Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · first_quarter · Medicare/Medicaid
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); Implementation of American Rescue Plan Act of 2021 (PL 117-2); Extension of the Medicare Sequester; S. 748, Medicare Sequester Relief Act; Telehealth issues related to COVID-19, including audio-only; S. 1971, Chronic Kidney Disease Improvement in Research and Treatment Act of 2021; H.R. 4065, To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes; End-Stage Renal Disease (ESRD) payment reform and quality metrics; Medicare kidney disease education benefit; S.377/H.R. 1255, Living Donor Protection Act; H.R. 1676, Jack Reynolds Memorial Medigap Expansion Act H.R. 3893, Coordination, Accountability, Research and Equity for All Kidneys Act of 2021 (CARE for All Kidneys Act); H.R. 2934, Renal Anemia Innovation Support and Expansion (RAISE) Act; End Stage Renal Disease (ESRD) Prospective Payment System (PPS) and utilization of calcimimetic drugs; Kildee/Wenstrup draft legislation to expand the ability of renal dialysis facilities to serve as originating sites for Medicare telehealth services
Client expense: Not reported · Firm income: $70,000
2022 · first_quarter · Medicare/Medicaid
Medicare organ and tissue donation and transplantation regulatory policy, awareness and education; H.R. 3893 - Care for All Kidneys Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · first_quarter · Health Issues
Organ and tissue donation and transplantation policy, awareness and education; H.R. 3893 - CARE for All Kidneys Act of 2021.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · first_quarter · Health Issues
Charitable premium assistance and end-stage renal disease issues; H.R. 1255/S. 377 Living Donor Protection Act; social determinants of health legislation, including H.R. 379/S. 104, Improving Social Determinants of Health Act of 2021; CARE for All Kidneys Act (H.R. 3893)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Medical/Disease Research/Clinical Labs
H.R. 1730, S. 670, Speeding Therapy Access Today Act of 2021; legislation regarding diagnosis and treatment of rare kidney diseases and related nephrology issues. H.R. 3893, Coordination, Accountability, Research, and Equity for All Kidneys Act of 2021. Congressional consideration of the Prescription Drug User Fee Act. H.R. 6963, Accelerated Approval Integrity Act, and H.R. 6996, Accelerated Access for Patient Act, and Senate proposals regarding expedited FDA pathways.
Client expense: $210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · fourth_quarter · Health Issues
H.R. 1255/S. 377, the Living Donor Protection Act H.R. 1676, the Jack Reynold Medigap Expansion Act H.R. 526, Ensuring Coverage in Public Health Emergencies Act of 2021 Increasing FMAP (Federal Medicare Assistance Percentage) Health disparities S. 1002, the Junk Plan Accountability and Disclosure Act of 2021 Organ Procurement Organizations Conditions for Coverage: Revisions to the Outcome Measure Requirements for Organ Procurement Organizations Part D Payment Modernization (PDM) Model for plan year 2022 Charitable Premium Assistance H.R. 3912/S. 1971, the Chronic Kidney Disease Improvement in Research and Treatment Act of 2021. H.R. 3893, the CARE for All Kidneys Act FY 2022, Labor-HHS-Education Appropriations Act
Client expense: $140,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2021 · fourth_quarter · Health Issues
H.R. 3893, Coordination, Accountability, Research and Equity (CARE) for All Kidneys Act of 2021 (generally, no specific provisions) H.R. 4356, Food and Drug Administration FY2022 Appropriations Act (Agriculture, Rural Development, FDA and Related Agencies Appropriations), provisions relating to encouraging the FDA to maintain its expertise in perfusion technologies and prioritize review of applications for such technologies Issues related to increasing organ transplantation to 50,000 per year (generally, no specific legislation) Issues related to addressing the shortage of crucial preservation solutions for safe organ transplantation (generally, no specific legislation)
Client expense: $120,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Charitable premium assistance and end-stage renal disease issues; H.R. 1255/S. 377 Living Donor Protection Act; social determinants of health legislation, including H.R. 379/S. 104, Improving Social Determinants of Health Act of 2021; CARE for All Kidneys Act (H.R. 3893)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Medicare/Medicaid
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); Implementation of American Rescue Plan Act of 2021 (PL 117-2); Continued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260); Extension of the Medicare Sequester; S. 748, Medicare Sequester Relief Act; Telehealth issues related to COVID-19, including audio-only; S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021; S. 1971, Chronic Kidney Disease Improvement in Research and Treatment Act of 2021; H.R. 4065, To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes; End-Stage Renal Disease (ESRD) payment reform and quality metrics; Medicare kidney disease education benefit; End Stage Renal Disease (ESRD) Treatment Choices Model (ETC Model) Proposed Rule (84 FR 34478, 7/18/19); S.377/H.R. 1255, Living Donor Protection Act; H.R. 1676, Jack Reynolds Memorial Medigap Expansion Act H.R. 3893, Coordination, Accountability, Research and Equity for All Kidneys Act of 2021 (CARE for All Kidneys Act); H.R. 2934, Renal Anemia Innovation Support and Expansion (RAISE) Act; PL-117-71 Protecting Medicare and American Families from Sequester Cuts Act - specifically: 6 months relief from 2% Medicare sequester, 4% statutory Pay-As-You-Go Act, 1 year relief of physician conversion factor cuts, 1 year delay of clinical lab (PAMA) cuts, delay of radiation oncology demo
Client expense: Not reported · Firm income: $70,000
2021 · fourth_quarter · Health Issues
Organ and tissue donation and transplantation policy, awareness and education; H.R. 3893 - CARE for All Kidneys Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2021 · fourth_quarter · Medicare/Medicaid
Medicare organ and tissue donation and transplantation policy, awareness and education; H.R. 3893 - Care for All Kidneys Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2021 · third_quarter · Medicare/Medicaid
Federal regulations and legislative issues related to organ donation and transplantation and other policy efforts to improve organ donation (no specific legislation or regulations). H.R. 3893, Coordination, Accountability, Research and Equity (CARE) for All Kidneys Act of 2021 (generally, no specific provisions). Issues related to expanding the Administrations Kidney Transplant collaborative to include other organs (generally, no specific language or regulations).
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
Federal regulations and legislative issues related to organ donation and transplantation and other policy efforts to improve organ donation (no specific legislation or regulations). H.R. 3893, Coordination, Accountability, Research and Equity (CARE) for All Kidneys Act of 2021 (generally, no specific provisions). Issues related to expanding the Administrations Kidney Transplant collaborative to include other organs (generally, no specific language or regulations).
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
H.R. 1255/S. 377, the Living Donor Protection Act H.R. 1676, the Jack Reynold Medigap Expansion Act H.R. 526, Ensuring Coverage in Public Health Emergencies Act of 2021 Increasing FMAP (Federal Medicare Assistance Percentage) Health disparities S. 1002, the Junk Plan Accountability and Disclosure Act of 2021 Organ Procurement Organizations Conditions for Coverage: Revisions to the Outcome Measure Requirements for Organ Procurement Organizations Part D Payment Modernization (PDM) Model for plan year 2022 Charitable Premium Assistance H.R. 3912/S. 1971, the Chronic Kidney Disease Improvement in Research and Treatment Act of 2021. H.R. 3893, the CARE for All Kidneys Act FY 2022, Labor-HHS-Education Appropriations Act
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2021 · third_quarter · Health Issues
Organ and tissue donation and transplantation policy, awareness and education; H.R. 3893 - CARE for All Kidneys Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
Charitable premium assistance and end-stage renal disease issues; H.R. 1255/S. 377 Living Donor Protection Act; social determinants of health legislation, including H.R. 379/S. 104, Improving Social Determinants of Health Act of 2021; CARE for All Kidneys Act (H.R. 3893)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Medicare/Medicaid
H.R. 3893 - Coordination, Accountability, Research, and Equity for All Kidneys Act of 2021.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Health Issues
H.R. 1255/S. 377, the Living Donor Protection Act H.R. 1676, the Jack Reynold Medigap Expansion Act H.R. 526, Ensuring Coverage in Public Health Emergencies Act of 2021 Increasing FMAP (Federal Medicare Assistance Percentage) Health disparities S. 1002, the Junk Plan Accountability and Disclosure Act of 2021 Organ Procurement Organizations Conditions for Coverage: Revisions to the Outcome Measure Requirements for Organ Procurement Organizations Part D Payment Modernization (PDM) Model for plan year 2022 Charitable Premium Assistance H.R. 3912/S. 1971, the Chronic Kidney Disease Improvement in Research and Treatment Act of 2021. H.R. 3893, the CARE for All Kidneys Act FY 2022, Labor-HHS-Education Appropriations Act
Client expense: $130,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2021 · second_quarter · Health Issues
Charitable premium assistance and end-stage renal disease issues; H.R. 1255/S. 377 Living Donor Protection Act; social determinants of health legislation, including H.R. 379/S. 104, Improving Social Determinants of Health Act of 2021; CARE for All Kidneys Act (H.R. 3893)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Medicare/Medicaid
H.R. 3893 - To improve kidney disease research, prevention, surveillance, and treatment in minority populations and rural and underserved communities, and for other purposes.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| DC |
| Linda T. Sánchez | Democratic | CA |
| Paul Tonko | Democratic | NY |
| Pete Aguilar | Democratic | CA |
| Raúl M. Grijalva | Democratic | AZ |
| Sanford D. Bishop, Jr. | Democratic | GA |
| Scott H. Peters | Democratic | CA |
| Susan Wild | Democratic | PA |
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE